Genprex, Inc. — Director's Dealing 2021

Mar 23, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Genprex, Inc. (GNPX)
CIK: 0001595248
Period of Report: 2021-03-19

Reporting Person: Varner John Rodney (Director, President & CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-19	Stock Option (right to buy)	$5.08	A	460000	Acquired	2031-03-19	Common Stock (460000)	Direct

Footnotes

F1: One third (1/3) of the Shares subject to the Option shall vest on each annual anniversary of March 19, 2021 so that one hundred percent (100%) of the shares subject to the Option are vested on the third anniversary of March 19, 2021 provided that the optionee continues to serve as a Service Provider (as defined in Genprex, Inc. 2018 Equity Incentive Plan) through the applicable vesting date.